PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD

A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HE, Xiaolian, WANG, Zhenzhong, DONG, Xuehong, XIAO, Wei, WANG, Yanqiu, ZHANG, Hui, GUO, Qingming, GU, Shasha
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HE, Xiaolian
WANG, Zhenzhong
DONG, Xuehong
XIAO, Wei
WANG, Yanqiu
ZHANG, Hui
GUO, Qingming
GU, Shasha
description A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023263789A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023263789A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023263789A13</originalsourceid><addsrcrecordid>eNrjZDAM8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw9HNRCAhyDXAMcgTzfV1DPPxdeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGRsZGZsbmFpaOhMXGqAA2yJ9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><source>esp@cenet</source><creator>HE, Xiaolian ; WANG, Zhenzhong ; DONG, Xuehong ; XIAO, Wei ; WANG, Yanqiu ; ZHANG, Hui ; GUO, Qingming ; GU, Shasha</creator><creatorcontrib>HE, Xiaolian ; WANG, Zhenzhong ; DONG, Xuehong ; XIAO, Wei ; WANG, Yanqiu ; ZHANG, Hui ; GUO, Qingming ; GU, Shasha</creatorcontrib><description>A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230824&amp;DB=EPODOC&amp;CC=US&amp;NR=2023263789A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230824&amp;DB=EPODOC&amp;CC=US&amp;NR=2023263789A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HE, Xiaolian</creatorcontrib><creatorcontrib>WANG, Zhenzhong</creatorcontrib><creatorcontrib>DONG, Xuehong</creatorcontrib><creatorcontrib>XIAO, Wei</creatorcontrib><creatorcontrib>WANG, Yanqiu</creatorcontrib><creatorcontrib>ZHANG, Hui</creatorcontrib><creatorcontrib>GUO, Qingming</creatorcontrib><creatorcontrib>GU, Shasha</creatorcontrib><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><description>A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAM8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw9HNRCAhyDXAMcgTzfV1DPPxdeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGRsZGZsbmFpaOhMXGqAA2yJ9A</recordid><startdate>20230824</startdate><enddate>20230824</enddate><creator>HE, Xiaolian</creator><creator>WANG, Zhenzhong</creator><creator>DONG, Xuehong</creator><creator>XIAO, Wei</creator><creator>WANG, Yanqiu</creator><creator>ZHANG, Hui</creator><creator>GUO, Qingming</creator><creator>GU, Shasha</creator><scope>EVB</scope></search><sort><creationdate>20230824</creationdate><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><author>HE, Xiaolian ; WANG, Zhenzhong ; DONG, Xuehong ; XIAO, Wei ; WANG, Yanqiu ; ZHANG, Hui ; GUO, Qingming ; GU, Shasha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023263789A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HE, Xiaolian</creatorcontrib><creatorcontrib>WANG, Zhenzhong</creatorcontrib><creatorcontrib>DONG, Xuehong</creatorcontrib><creatorcontrib>XIAO, Wei</creatorcontrib><creatorcontrib>WANG, Yanqiu</creatorcontrib><creatorcontrib>ZHANG, Hui</creatorcontrib><creatorcontrib>GUO, Qingming</creatorcontrib><creatorcontrib>GU, Shasha</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HE, Xiaolian</au><au>WANG, Zhenzhong</au><au>DONG, Xuehong</au><au>XIAO, Wei</au><au>WANG, Yanqiu</au><au>ZHANG, Hui</au><au>GUO, Qingming</au><au>GU, Shasha</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><date>2023-08-24</date><risdate>2023</risdate><abstract>A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2023263789A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A49%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HE,%20Xiaolian&rft.date=2023-08-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023263789A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true